Skip to main content
. 2014 Feb 18;9(2):e89072. doi: 10.1371/journal.pone.0089072

Figure 3. Crude and Cluster-adjusted analysis of CKD patients’ CND prescription by GP.

Figure 3

Distribution (%) of CKD patients who received at least one prescription of contraindicated nephrotoxic drugs (CND) within the year prior (A) and after (B) first CKD diagnosis, clustered by GP. The distribution was clustered by GP and the was adjusted also by sex and age. CND: contraindicated nephrotoxic drug.